- H.R. 10171August 27, 2026
- H.R. 10156August 27, 2026
- H.R. 10172August 27, 2026
- H.R. 10160August 27, 2026
- H.R. 10181August 27, 2026
- H.R. 10176August 27, 2026
- H.Res. 1496August 27, 2026
- H.R. 10164August 27, 2026
- H.R. 10170August 27, 2026
- H.Res. 1494August 27, 2026
- H.R. 10163August 27, 2026
- H.R. 10157August 27, 2026
- Administration
- Agriculture
- Agriculture, Nutrition, And Forestry
- Appropriations
- Armed Services
- Banking, Housing, And Urban Affairs
- Budget
- Commerce, Science, And Transportation
- Education and Workforce
- Energy And Commerce
- Energy And Natural Resources
- Environment And Public Works
- Ethics
- Finance
- Financial Services
- Foreign Affairs
- Foreign Relations
- Health, Education, Labor, And Pensions
- Homeland Security
- Homeland Security And Governmental Affa…
- Indian Affairs
- Indian and Insular Affairs
- Intelligence
- Judiciary
- Natural Resources
- Oversight And Government Reform
- Permanent Select Intelligence
- Rules
- Rules And Administration
- Science, Space, And Technology
- Select Intelligence
- Small Business
- Small Business And Entrepreneurship
- Subcommittee on Aviation
- Subcommittee on Border Security and Enf…
- Subcommittee on Coast Guard and Maritim…
- Subcommittee on Commodity Markets, Digi…
- Subcommittee on Conservation, Research,…
- Subcommittee on Counterterrorism and In…
- Subcommittee on Cybersecurity and Infra…
- Subcommittee on Disability Assistance a…
- Subcommittee on Economic Development, P…
- Subcommittee on Economic Opportunity
- Subcommittee on Emergency Management an…
- Subcommittee on Energy and Mineral Reso…
- Subcommittee on Federal Lands
- Subcommittee on Forestry and Horticultu…
- Subcommittee on General Farm Commoditie…
- Subcommittee on Health
- Subcommittee on Highways and Transit
- Subcommittee on Livestock, Dairy, and P…
- Subcommittee on Nutrition and Foreign A…
- Subcommittee on Oversight and Investiga…
- Subcommittee on Oversight, Investigatio…
- Subcommittee on Railroads, Pipelines, a…
- Subcommittee on Transportation and Mari…
- Subcommittee on Water Resources and Env…
- Subcommittee on Water, Wildlife and Fis…
- Transportation And Infrastructure
- Veterans' Affairs
- Ways And Means

S. 3452
U.S. Senate•In Senate Committee
Summary
S. 3452, the Biological Intellectual Property Protection Act of 2025, was introduced in the Senate on Dec 11, 2025 by Sen. Tom Cotton (R) with 3 co-sponsors. It was referred to Banking, Housing, And Urban Affairs, and last saw action on Dec 11, 2025: Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
Record
Text
S. 3452 has 3 co-sponsors.
sb3452/introduced-in-senate.txt119 S3452 IS: Biological Intellectual Property Protection Act of 2025U.S. Senate2025-12-11text/xmlENPursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.II 119th CONGRESS 1st Session S. 3452 IN THE SENATE OF THE UNITED STATES December 11, 2025 Mr. Cotton (for himself, Ms. Hassan , and Mr. Budd ) introduced the following bill; which was read twice and referred to the Committee on Banking, Housing, and Urban Affairs A BILLTo restrict the export to foreign entities of concern of United States intellectual property and sensitive information related to synthetic biology, and for other purposes.1.Short titleThis Act may be cited as the Biological Intellectual Property Protection Act of 2025 .2.Sense of CongressIt is the sense of Congress that—(1)the People’s Republic of China is conducting a systematic campaign to access and exploit sensitive United States data and intellectual property to modernize its military, intelligence, and other security apparatuses, enable human rights abuses, and develop dual-use strategic technologies;(2)access by the People's Republic of China to sensitive United States data and intellectual property poses grave and direct threats to United States national security;(3)the efforts of the People's Republic of China to access such data and intellectual property are supported by a military-civil fusion strategy, through which the People's Republic of China increases the size of its military-industrial complex by compelling civilian Chinese companies and research institutions to support its military and intelligence activities, which results in ostensibly private and civilian companies that access United States capital supporting the modernization of the People’s Liberation Army;(4)the law of the People's Republic of China requires that all citizens of the People's Republic of China cooperate with national security priorities, enabling the modernization of the People’s Liberation Army, including through—(A)the National Security Law of 2015, which states that citizens of the People's Republic of China shall have duties and obligations to maintain national security ;(B)the National Intelligence Law of 2017, which states that all organizations and citizens shall support, assist, and cooperate with national intelligence work ;(C)the Data Security Law of 2021, which states that where a public security organ or national security organ needs to obtain data for the sake of national security or for investigating crimes in accordance with the law … the relevant organizations and individuals shall cooperate ; and(D)the Counterespionage Law, revised in 2023, which states that citizens of the People's Republic of China have the duty to maintain the security, honor and interests of the state, and shall not engage in any act that endangers the security, honor or interests of the state ;(5)the export of novel synthetic DNA and RNA sequences provides insight into the designs and research of biotechnology entities, leading to a high potential for intellectual property theft by foreign adversaries; and(6)the United States should therefore control the export of synthetic DNA and RNA sequences to foreign adversaries.3.License requirement to protect United States intellectual property and sensitive information related to synthetic biologyPart I of the Export Control Reform Act of 2018 ( 50 U.S.C. 4811 et seq. ) is amended by inserting after section 1758 the following:1758A.License requirement to protect United States intellectual property and sensitive information related to synthetic biology(a)License requirementNot later than 1 year after the date of the enactment of this section, the Secretary shall, except as provided for in subsection (b), require a license for the export, reexport, or in-country transfer to a foreign entity of concern of a digital sequence of synthetic DNA or RNA designed by humans or artificial intelligence systems.(b)ExceptionThe requirement for a license under subsection (a) shall not apply with respect to information described in section 734.3(b) of the Export Administration Regulations.(c)DefinitionsIn this section:(1)Digital sequenceThe term digital sequence means a binary file or other digital representation containing symbols representing the identity, order, and any chemical modification for each position in a DNA or RNA molecule.(2)Foreign country of concernThe term foreign country of concern has the meaning given that term in section 10612(a) of the Research and Development, Competition, and Innovation Act ( 42 U.S.C. 19221(a) ).(3)Foreign entity of concernThe term foreign entity of concern means—(A)a government entity of a foreign country of concern;(B)a foreign person subject to the jurisdiction of, or organized under the laws of, a foreign country of concern; or(C)a foreign person owned, directed, or controlled by an entity described in subparagraph (A) or (B).(4)Synthetic DNA or RNAThe term synthetic DNA or RNA means—(A)molecules that are constructed by joining nucleic acid molecules and can replicate in a living cell, such as recombinant nucleic acids;(B)nucleic acid molecules that are chemically or by other means synthesized, including such molecules that are chemically or otherwise modified but can base pair with naturally occurring nucleic acid molecules, such as synthetic nucleic acids; or(C)molecules that result from the replication of molecules described in subparagraph (A) or (B)..
Tracker
The tracker indicates the progress of this legislation as it moves through the legislative process.
- Introduced2025-12-11
- Passed Senate
- Passed House
- Conference
- To President
- Became Law
A bill to restrict the export to foreign entities of concern of United States intellectual property and sensitive information related to synthetic biology, and for other purposes.
Sponsors
Sen. Tom Cotton (R) sponsors S. 3452, and 3 members have co-sponsored it, 2 of them from the day it was introduced.
Committees
S. 3452 went before 1 committee: Banking, Housing, and Urban Affairs.

Actions
S. 3452 has taken 2 actions since Dec 11, 2025.
| Chamber | Action | |||
|---|---|---|---|---|
Dec 11, 2025 | Senate | Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.Banking, Housing, and Urban Affairs Committee | ||
Dec 11, 2025 | — | Introduced in Senate |
Votes
S. 3452 has not gone to a roll call.
Related bills
1 bill is related to S. 3452, as Identical bill.
Titles
S. 3452 goes by 3 titles, 1 of them short titles.
- Biological Intellectual Property Protection Act of 2025 — Display Title
- Biological Intellectual Property Protection Act of 2025 — Short Title(s) as Introduced
- A bill to restrict the export to foreign entities of concern of United States intellectual property and sensitive information related to synthetic biology, and for other purposes. — Official Title as Introduced
Lobbying
5 clients hired 5 firms and 52 registered lobbyists who named S. 3452 in 8 quarterly filings, 2025 to 2026. Reported under the Lobbying Disclosure Act; a filing’s income covers everything its registrant worked that quarter, so the amounts below are the filings’, not this bill’s.
Filed under Trade (domestic/foreign), Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid, Science/Technology, Budget/Appropriations, Defense, Tariff (miscellaneous tariff bills).
Clients
Who paid to be heard, by how many filings named the bill.
| Client | Business | State | Firms | Filings | Reported |
|---|---|---|---|---|---|
| TWIST BIOSCIENCE CORPORATION | Manufactures synthetic DNA for clients in the biotechnology industry. | California | 1 | 3 | $240K |
| AMGEN INC | — | District of Columbia | 1 | 2 | — |
| FDD ACTION | — | District of Columbia | 1 | 1 | — |
| GSK (FKA GLAXOSMITHKLINE INC.) | — | District of Columbia | 1 | 1 | — |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | — | District of Columbia | 1 | 1 | — |
Firms
Registrants who filed on the bill, by filings.
| Registrant | Clients | Filings | Reported |
|---|---|---|---|
| IPOLICY SOLUTIONS | 1 | 3 | $240K |
| AMGEN, INC. | 1 | 2 | — |
| FDD ACTION | 1 | 1 | — |
| GSK (FKA GLAXOSMITHKLINE INC.) | 1 | 1 | — |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 1 | 1 | — |
Lobbyists
Named on the filings that cite the bill. The 20 named most often, of 52.
| Lobbyist | Firms | Clients | Filings |
|---|---|---|---|
| JENNIFER LEIB | 1 | 1 | 3 |
| LINDSEY TRISCHLER | 1 | 1 | 3 |
| MEGAN ANDERSON BROOKS | 1 | 1 | 3 |
| CHAD PETTIT | 1 | 1 | 2 |
| CHASE THOMAS | 1 | 1 | 2 |
| GREGORY PORTNER | 1 | 1 | 2 |
| HELEN RHEE | 1 | 1 | 2 |
| HOWARD MOON | 1 | 1 | 2 |
| JESSE KERNS | 1 | 1 | 2 |
| JORDAN LAYSON | 1 | 1 | 2 |
| KIMBERLY LOVE | 1 | 1 | 2 |
| L CURRIE | 1 | 1 | 2 |
| MATTHEW MCMURRAY | 1 | 1 | 2 |
| RUTH HOFFMAN | 1 | 1 | 2 |
| WILLIAM O'BRIEN | 1 | 1 | 2 |
| ALEXANDRIA PAOLOZZI MOORE | 1 | 1 | 1 |
| ANNIE WOERPEL | 1 | 1 | 1 |
| BART FORSYTH | 1 | 1 | 1 |
| BRENTON FISK | 1 | 1 | 1 |
| CARA WALTHER | 1 | 1 | 1 |
Filings
The documents themselves, on the Senate’s Lobbying Disclosure site, largest reported first.
| Client | Registrant | Period | Reported | Document |
|---|---|---|---|---|
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 2026 second_quarter | $7.4M | 2nd Quarter - Report |
| AMGEN INC | AMGEN, INC. | 2026 first_quarter | $2.6M | 1st Quarter - Report |
| AMGEN INC | AMGEN, INC. | 2026 second_quarter | $2.4M | 2nd Quarter - Report |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 2026 second_quarter | $890K | 2nd Quarter - Report |
| FDD ACTION | FDD ACTION | 2026 second_quarter | $240K | 2nd Quarter - Report |
| TWIST BIOSCIENCE CORPORATION | IPOLICY SOLUTIONS | 2026 second_quarter | $82.5K | 2nd Quarter - Report |
| TWIST BIOSCIENCE CORPORATION | IPOLICY SOLUTIONS | 2026 first_quarter | $82.5K | 1st Quarter - Report |
| TWIST BIOSCIENCE CORPORATION | IPOLICY SOLUTIONS | 2025 fourth_quarter | $75K | 4th Quarter - Report |
Classification
The Congressional Research Service files S. 3452 under International Affairs, one of its 31 policy areas.
CRS Subjects
CRS assigns every bill one policy area from its 31; S. 3452’s is International Affairs.
s3452/policy-areas.txtSource: congress.gov · legiscan.com
